FNCHFinch Therapeutics Group Inc

$7.50
$0.05
(0.66%)
Today
Updated: 02:12 PM EDT
Reported EarningsMay 10
Mkt Cap$12.04M
Vol1,096.00

About

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Finch Therapeutics Group Inc?
What is the 52-week high for Finch Therapeutics Group Inc?
What is the 52-week low for Finch Therapeutics Group Inc?
What is Finch Therapeutics Group Inc stock price today?
What was Finch Therapeutics Group Inc stock price yesterday?
What is the 50-day moving average of Finch Therapeutics Group Inc?

Latest FNCH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.